Neuro-oncology
Clinical research is focused on newly diagnosed glioblastoma, with attention to treatment strategies for aggressive brain tumours.
- Glioblastoma
- Brain cancer
- Central nervous system oncology
The sponsor’s research activity is centred on therapeutic approaches used alongside radiotherapy and temozolomide in the management of high-grade glioma.
Radiation-based cancer treatment
Interest extends to the use of radiochemotherapy in combination with novel agents for tumour control in the central nervous system.
- Radiotherapy
- Concomitant chemoradiation
- Tumour radiosensitisation
Research activity reflects a focus on integrating treatment modalities for patients with newly diagnosed malignant brain disease.
Nanomedicine
The sponsor is involved in research on nanoparticle-based therapeutics, particularly AGuIX nanoparticles in oncological care.
- Nanoparticle delivery
- Medical nanotechnology
- Targeted oncology agents
This area links advanced material-based therapies with treatment of glioblastoma in a clinical setting.
Temozolomide-based oncology
Research activity also covers the clinical use of temozolomide within combined treatment approaches for high-grade glioma.
- Alkylating chemotherapy
- Combined modality therapy
- Glioma pharmacotherapy
The therapeutic emphasis is on drug combinations used during the concomitant radiochemotherapy period.
